This Agomab Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Nuvectis Pharma, Inc.
JBT Marel Corporation
AgomAb Therapeutics NV ADR
Jersey Mike's Subs, Inc. Class A
Apnimed, Inc.
Nuvectis Pharma, Inc. NVCT | 0.00 | |
JBT Marel Corporation JBTM | 0.00 | |
AgomAb Therapeutics NV ADR AGMB | 0.00 | |
Jersey Mike's Subs, Inc. Class A JMKE | 0.00 | |
Apnimed, Inc. APMD | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Goldman Sachs analyst Leah Jordan initiated coverage on Jersey Mike’s Subs (NYSE:JMKE) with a Neutral rating and announced a price target of $26. Jersey Mike’s Subs closed at $23.53 on Monday. See how other analysts view this stock.
- Piper Sandler analyst Yasmeen Rahimi initiated coverage on Agomab Therapeutics NV (NASDAQ:AGMB) with an Overweight rating and announced a price target of $60. AgomAb Therapeutics shares closed at $12.82 on Monday. See how other analysts view this stock.
- B of A Securities analyst Jason Gerberry initiated coverage on Apnimed Inc (NASDAQ:APMD) with a Buy rating and announced a price target of $41. Apnimed closed at $25.63 on Monday. See how other analysts view this stock.
- Keybanc analyst Jeffrey Hammond initiated coverage on JBT Marel Corp (NYSE:JBTM) with an Overweight rating and announced a price target of $150. JBT Marel shares closed at $115.08 on Monday. See how other analysts view this stock.
- Oppenheimer analyst Colin Rusch initiated coverage on Kodiak AI Inc (NASDAQ:KDK) with an Outperform rating and announced a price target of $9. Kodiak AI closed at $3.79 on Monday. See how other analysts view this stock.
Considering buying AGMB stock? Here’s what analysts think:
Photo via Shutterstock